Interiglin 20mg Injection
Marketer
MSD Pharmaceuticals Pvt Ltd
Salt Composition
Eptifibatide (20mg)
Overview Interiglin 20mg Injection
CardioGuard 20mg Injection is an anticoagulant preventing the development of dangerous blood clots. It's indicated in acute myocardial infarction treatment and to inhibit clot formation during angioplasty (a procedure enhancing coronary blood flow). Administration of CardioGuard 20mg Injection requires physician oversight; dosage and treatment length are determined individually. Concurrently prescribed medications should be continued as directed. Thrombocytopenia and heightened bleeding risk are potential adverse effects. Report any petechiae or blood in emesis, urine, or feces promptly. Hypotension is another possible side effect. Your physician will discuss the treatment's benefits and risks before administration. Caution is advised in certain patients. Prior to treatment, disclose any bleeding disorders, hepatic or renal impairment, pregnancy, breastfeeding, and all other concurrent medications.
Uses of Interiglin 20mg Injection
Thrombosis prophylaxis | Myocardial infarction prevention
Major Benefits of Interiglin 20mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
Common Side effects of Interiglin 20mg Injection:
- Bleeding
- Decreased blood pressure
How to use Interiglin 20mg Injection:
The medication will be administered by your physician or their designated nurse. Self-medication is strongly discouraged.
How Interiglin 20mg Injection works:
Iriglin 20mg Injection is an antithrombotic agent that inhibits platelet aggregation, thus reducing the risk of dangerous clot development.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Interiglin 20mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Use of Interiglin 20mg Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Interiglin 20mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingNOT RELEVANT
Interiglin 20mg Injection is administered solely within a hospital setting.
KidneyCAUTION
Patients with kidney impairment should receive Interiglin 20mg Injection cautiously, potentially requiring dosage modification. Consult a physician before administration. Interiglin 20mg Injection is contraindicated in individuals with severely compromised kidney function.
LiverCONSULT YOUR DOCTOR
Data on Interiglin 20mg Injection use in patients with hepatic impairment is scarce. Physician consultation is advised. Interiglin 20mg Injection is contraindicated in patients with severe liver dysfunction.
What if you forget to take Interiglin 20mg Injection :
Forgetting a dose of Interiglin 20mg Injection? Seek medical advice.
Facts to Know About Interiglin 20mg Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide and amino acid analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | IIb/IIIa receptor antagonists |
3,018 People bought this recently